Technology: Cyrus Biotechnology and CRISPR pioneers team up to boost gene-editing therapies - - PressFrom - US
  •   
  •   
  •   

Technology Cyrus Biotechnology and CRISPR pioneers team up to boost gene-editing therapies

02:55  03 december  2019
02:55  03 december  2019 Source:   geekwire.com

Miley Cyrus and Cody Simpson Have 'No Plans to Start Dating' Following PDA, Source Says

  Miley Cyrus and Cody Simpson Have 'No Plans to Start Dating' Following PDA, Source Says Washington Redskins head coach Jay Gruden announces Colt McCoy will start Week 5.

CRISPR gene editing is a method by which the genomes of living organisms may be edited. It is based on a simplified version of the bacterial CRISPR /Cas ( CRISPR -Cas9) antiviral defense system.

Genome editing (also called gene editing ) is a group of technologies that give scientists the ability to CRISPR -Cas9 was adapted from a naturally occurring genome editing system in bacteria. Germline cell and embryo genome editing bring up a number of ethical challenges, including whether

Seattle-based Cyrus Biotechnology says it’ll collaborate with the Broad Institute of MIT and Harvard on ways to optimize CRISPR gene-editing techniques for use in developing novel human therapeutics.

Feng Zhang standing in front of a refrigerator: MIT researcher Feng Zhang will be the principal investigator for the Broad Institute’s collaboration with Cyrus Biotechnology. (HHMI Photo)© Provided by Geekwire MIT researcher Feng Zhang will be the principal investigator for the Broad Institute’s collaboration with Cyrus Biotechnology. (HHMI Photo)
  • CRISPR has revolutionized genetics by making it easier to modify the DNA coding in the genome, but more needs to be done to address safety concerns for human applications. Cyrus Biotech and the Broad Institute will work on ways to reduce the potential for the body to mount an immune response against CRISPR-based therapies.
  • MIT biochemist Feng Zhang, one of the pioneers in the development of CRISPR, will be the principal investigator for the effort at the Broad Institute. The results of the collaboration will be published in peer-reviewed journals and made freely available to the academic and non-profit scientific community.
  • Privately held Cyrus Biotech offers software and partnerships to accelerate the discovery of engineered proteins, primarily for therapeutic applications. Its software tools are derived from the Rosetta protein-modeling platform, which was developed at the University of Washington.

Cyrus Biotechnology and CRISPR pioneers team up to boost gene-editing therapies .
Rockets center Clint Capela is likely to return for Tuesday’s game at division rival San Antonio after missing Houston’s last two games with an illness However, forward Danuel House Jr. is likely to remain out with an illness of his own, which started a few days later Thus, he hasn’t had the same recovery time Capela missed both Wednesday’s win over Miami and Saturday’s blowout of Atlanta, while House missed just the second game

—   Share news in the SOC. Networks
usr: 1
This is interesting!